Preoperative Oral ImmunoNuTrition to Improve Surgical Outcomes for IBD Patients (PINT)
Status:
Withdrawn
Trial end date:
2022-01-01
Target enrollment:
Participant gender:
Summary
The central focus of this trial is to understand the effectiveness of Preoperative
Immunonutrition (PINT) in improving surgical outcomes for patients with inflammatory bowel
disease (IBD). We hypothesize that PINT will reduce post-operative complications in IBD
patients undergoing elective surgery with added improvements in length-of-stay (LOS), quality
of life (QOL) and patient satisfaction. As a secondary focus, the investigator will aim to
better understand the potential mechanism-of-action by which PINT may have its effects
through analyses of biomarkers including inflammatory markers, nutritional proteins and the
fecal microbiome.